Transcutaneous electrical vagus nerve stimulation to suppress premature ventricular complexes (TREAT PVC): study protocol for a multi-center, double-blind, randomized controlled trial
DiscussionThe present trial will be the first to evaluate the effect of LLTS on frequent PVCs on patients without SHD. LLTS may serve as a low-cost, minimal-risk, and non-invasive alternative to conventional antiarrhythmic therapy.Trial registrationClinicalTrial.gov NCT04909528. Registered on 17 June 2021. World health organization trial registration data set was shown in Supplementary Table1.
Source: Trials - Category: Research Source Type: clinical trials
More News: Arrhythmia | Atrial Fibrillation | Brain | Cardiology | Electrocardiogram | Heart | Heart Disease | International Medicine & Public Health | Neurology | Reflex Sympathetic Dystrophy | Research | Skin | Study | Vagus Nerve Stimulation Therapy | WHO